From: Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
Variables | Ā | Ā | Disease-specific survival | Overall survival | ||||
---|---|---|---|---|---|---|---|---|
Ā | Ā | N | HR | 95% CI | p | HR | 95% CI | p |
Age (yrs) | Ā | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā | ā¤ 65 | 35 | 1 | Ā | Ā | 1 | Ā | Ā |
Ā | > 65 | 107 | 1.88 | 0.69ā5.08 | 0.21 | 2.03 | 0.78ā5.25 | 0.15 |
Sex | Ā | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā | Male | 115 | 1 | Ā | Ā | 1 | Ā | Ā |
Ā | Female | 27 | 1.45 | 0.47ā4.46 | 0.52 | 1.3 | 0.44ā3.86 | 0.63 |
Tumor grade | Ā | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā | Low | 11 | 1 | Ā | Ā | 1 | Ā | Ā |
Ā | High | 131 | 2.97 | 0.42ā20.90 | 0.27 | 2.99 | 0.46ā19.58 | 0.25 |
Stage | Ā | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā | NMIBC | 82 | 1 | Ā | Ā | 1 | Ā | Ā |
Ā | MIBC | 60 | 11.78 | 4.71ā29.43 | <0.0001 | 8.83 | 3.65ā21.32 | 0.0015 |
Combined immunostaining score for CXCL1 | Ā | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā | None / Low | 34 | 1 | Ā | Ā | 1 | Ā | Ā |
Ā | Moderate | 53 | 3.45 | 0.84ā14.13 | 0.085 | 2.68 | 0.76ā9.50 | 0.13 |
Ā | High | 55 | 5.73 | 1.92ā17.10 | 0.0018 | 4.63 | 1.60ā13.37 | 0.0047 |